Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carole Henique

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Current Opinion in Nephrology and Hypertension|June 5, 2012
Targeting signaling pathways in glomerular diseasesCarole Henique, Pierre-Louis Tharaux
Bio-Protocol|March 3, 2021
Immunofluorescence staining of WT-1/Podocalyxin on Mouse kidney sectionsCarole Henique, Olivia Lenoir, Pierre-Louis Tharaux
Diagnostics (Basel, Switzerland)|April 30, 2021
Nephrotoxicity of Anti-Angiogenic TherapiesMargaux Van Wynsberghe, Joanne Flejeo, Hamza Sakhi, et al.
European Journal of Cancer (Oxford, England : 1990)|October 4, 2020
Acute tubular necrosis after selective FGFR tyrosine kinase inhibitor therapyAnissa Moktefi, Carolina Saldana, Thomas Stehlé, et al.
The Journal of Biological Chemistry|September 15, 2010
Increased mitochondrial fatty acid oxidation is sufficient to protect skeletal muscle cells from palmitate-induced apoptosisCarole Henique, Abdelhak Mansouri, Gwladys Fumey, et al.
Clinical and Translational Medicine|July 29, 2021
CMIP interacts with WT1 and targets it on the proteasome degradation pathwayShao-Yu Zhang, Qingfeng Fan, Anissa Moktefi, et al.
Journal of Autoimmunity|October 24, 2017
NEPHRUTIX: A randomized, double-blind, placebo vs Rituximab-controlled trial assessing T-cell subset changes in Minimal Change Nephrotic SyndromeAhmed Boumediene, Pauline Vachin, Kelhia Sendeyo, et al.
Molecular and Cellular Biology|September 4, 2008
The transcription factor COUP-TFII is negatively regulated by insulin and glucose via Foxo1- and ChREBP-controlled pathwaysAnaïs Perilhou, Cécile Tourrel-Cuzin, Ilham Kharroubi, et al.
Journal of the American Society of Nephrology : JASN|November 30, 2016
Sildenafil Prevents Podocyte Injury <i>via</i> PPAR-<i>γ</i>-Mediated TRPC6 InhibitionRamon Sonneveld, Joost G Hoenderop, Andrea M Isidori, et al.
Cellular & Molecular Immunology|August 10, 2019
CMIP is a negative regulator of T cell signalingJulie Oniszczuk, Kelhia Sendeyo, Cerina Chhuon, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Current Opinion in Nephrology and Hypertension|June 5, 2012
Targeting signaling pathways in glomerular diseasesCarole Henique, Pierre-Louis Tharaux
Bio-Protocol|March 3, 2021
Immunofluorescence staining of WT-1/Podocalyxin on Mouse kidney sectionsCarole Henique, Olivia Lenoir, Pierre-Louis Tharaux
Diagnostics (Basel, Switzerland)|April 30, 2021
Nephrotoxicity of Anti-Angiogenic TherapiesMargaux Van Wynsberghe, Joanne Flejeo, Hamza Sakhi, et al.
European Journal of Cancer (Oxford, England : 1990)|October 4, 2020
Acute tubular necrosis after selective FGFR tyrosine kinase inhibitor therapyAnissa Moktefi, Carolina Saldana, Thomas Stehlé, et al.
The Journal of Biological Chemistry|September 15, 2010
Increased mitochondrial fatty acid oxidation is sufficient to protect skeletal muscle cells from palmitate-induced apoptosisCarole Henique, Abdelhak Mansouri, Gwladys Fumey, et al.
Clinical and Translational Medicine|July 29, 2021
CMIP interacts with WT1 and targets it on the proteasome degradation pathwayShao-Yu Zhang, Qingfeng Fan, Anissa Moktefi, et al.
Journal of Autoimmunity|October 24, 2017
NEPHRUTIX: A randomized, double-blind, placebo vs Rituximab-controlled trial assessing T-cell subset changes in Minimal Change Nephrotic SyndromeAhmed Boumediene, Pauline Vachin, Kelhia Sendeyo, et al.
Molecular and Cellular Biology|September 4, 2008
The transcription factor COUP-TFII is negatively regulated by insulin and glucose via Foxo1- and ChREBP-controlled pathwaysAnaïs Perilhou, Cécile Tourrel-Cuzin, Ilham Kharroubi, et al.
Journal of the American Society of Nephrology : JASN|November 30, 2016
Sildenafil Prevents Podocyte Injury <i>via</i> PPAR-<i>γ</i>-Mediated TRPC6 InhibitionRamon Sonneveld, Joost G Hoenderop, Andrea M Isidori, et al.
Cellular & Molecular Immunology|August 10, 2019
CMIP is a negative regulator of T cell signalingJulie Oniszczuk, Kelhia Sendeyo, Cerina Chhuon, et al.
Pageof 2